ArticleCancer gene therapy2025

Real-world outcomes of Adjuvant De Gramont versus Xelox chemotherapy in reSected gasTric cancER: a propensity score-matched analysis (ASTER study).

Ina Valeria Zurlo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.